Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03443856
Title Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence (VESTIGE)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | child | senior
Covered Countries ITA | FRA | ESP | DEU


No variant requirements are available.